Triglyceride-Rich Lipoproteins and Atherosclerotic Cardiovascular Disease: New Insights From Epidemiology, Genetics, and Biology

Circulation Research
Børge G Nordestgaard

Abstract

Scientific interest in triglyceride-rich lipoproteins has fluctuated over the past many years, ranging from beliefs that these lipoproteins cause atherosclerotic cardiovascular disease (ASCVD) to being innocent bystanders. Correspondingly, clinical recommendations have fluctuated from a need to reduce levels to no advice on treatment. New insight in epidemiology now suggests that these lipoproteins, marked by high triglycerides, are strong and independent predictors of ASCVD and all-cause mortality, and that their cholesterol content or remnant cholesterol likewise are strong predictors of ASCVD. Of all adults, 27% have triglycerides >2 mmol/L (176 mg/dL), and 21% have remnant cholesterol >1 mmol/L (39 mg/dL). For individuals in the general population with nonfasting triglycerides of 6.6 mmol/L (580 mg/dL) compared with individuals with levels of 0.8 mmol/L (70 mg/dL), the risks were 5.1-fold for myocardial infarction, 3.2-fold for ischemic heart disease, 3.2-fold for ischemic stroke, and 2.2-fold for all-cause mortality. Also, genetic studies using the Mendelian randomization design, an approach that minimizes problems with confounding and reverse causation, now demonstrate that triglyceride-rich lipoproteins are causally asso...Continue Reading

References

Nov 15, 1991·Proceedings of the National Academy of Sciences of the United States of America·S Ylä-HerttualaJ L Witztum
May 1, 1990·Arteriosclerosis : an Official Journal of the American Heart Association, Inc·B G NordestgaardK Kjeldsen
Mar 1, 1989·Arteriosclerosis : an Official Journal of the American Heart Association, Inc·B G Nordestgaard, D B Zilversmit
Aug 5, 1988·JAMA : the Journal of the American Medical Association·V ManninenP Koskinen
Jul 1, 1988·Arteriosclerosis : an Official Journal of the American Heart Association, Inc·B G NordestgaardK Kjeldsen
Sep 1, 1984·Arteriosclerosis : an Official Journal of the American Heart Association, Inc·H C McGill
Jan 1, 1981·Arteriosclerosis : an Official Journal of the American Heart Association, Inc·S Stender, D B Zilversmit
Aug 1, 1994·Current Opinion in Lipidology·B G Nordestgaard, L B Nielsen
Oct 1, 1996·Current Opinion in Lipidology·B G Nordestgaard
Apr 1, 1997·The Journal of Clinical Investigation·H H WittrupB G Nordestgaard
Jun 22, 1999·The Journal of Clinical Investigation·V R BabaevM F Linton
Jun 15, 2000·Proceedings of the National Academy of Sciences of the United States of America·M L BrownS H Gianturco
Jul 6, 2000·Circulation·UNKNOWN Bezafibrate Infarction Prevention (BIP) study
May 23, 2001·JAMA : the Journal of the American Medical Association·UNKNOWN Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults
Sep 28, 2002·Current Opinion in Lipidology·Spencer D ProctorJohn C L Mamo
Apr 12, 2003·International Journal of Epidemiology·George Davey Smith, Shah Ebrahim
Apr 13, 2004·International Journal of Epidemiology·George Davey Smith, Shah Ebrahim
Jun 1, 2004·Experimental Biology and Medicine·Kelly V BattKathleen M Botham
Sep 10, 2004·Journal of Atherosclerosis and Thrombosis·Sadao TakahashiTokuo T Yamamoto
Oct 1, 1949·Proceedings of the Society for Experimental Biology and Medicine·G C McGILL, R L HOLMAN
Mar 2, 2006·European Journal of Clinical Investigation·T UelandA G Semb
Jul 20, 2007·JAMA : the Journal of the American Medical Association·Børge G NordestgaardAnne Tybjaerg-Hansen
Jul 20, 2007·JAMA : the Journal of the American Medical Association·Sandeep BansalPaul M Ridker
Sep 21, 2007·Atherosclerosis·Ian GrahamUNKNOWN ESC Committee for Practice Guidelines
Sep 22, 2007·Statistics in Medicine·Debbie A LawlorGeorge Davey Smith
Nov 7, 2007·The New England Journal of Medicine·Philip J BarterUNKNOWN ILLUMINATE Investigators
Jun 1, 1949·The Journal of Experimental Medicine·G L DUFF, G C McMILLAN
Feb 19, 2008·Journal of the American College of Cardiology·Michael MillerUNKNOWN PROVE IT-TIMI 22 Investigators
Jun 4, 2008·Circulation·John J P KasteleinUNKNOWN IDEAL Study Group
Jun 5, 2008·JAMA : the Journal of the American Medical Association·Ruth Frikke-SchmidtAnne Tybjaerg-Hansen
Nov 13, 2008·JAMA : the Journal of the American Medical Association·Jacob J FreibergBørge G Nordestgaard

❮ Previous
Next ❯

Citations

Jul 5, 2016·The British Journal of Nutrition·Nadia MansoorKjetil Retterstøl
Jan 26, 2017·European Journal of Preventive Cardiology·Stephen J NichollsDiederick E Grobbee
Feb 9, 2017·Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology·Wei HeLujun Gu
Mar 17, 2017·Nature Reviews. Cardiology·Željko Reiner
Jan 27, 2017·Annals of Nutrition & Metabolism·Joyce A NettletonGerard Hornstra
Mar 25, 2017·Expert Review of Cardiovascular Therapy·Michael DavidsonJoseph L Witztum
Feb 12, 2017·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Matteo PirroAmirhossein Sahebkar
Apr 12, 2017·European Journal of Internal Medicine·Domenico GirelliOliviero Olivieri
May 16, 2017·Current Opinion in Cardiology·June KampangkaewVijay Nambi
Jan 19, 2017·Current Opinion in Endocrinology, Diabetes, and Obesity·Charlotte KoopalFrank L J Visseren
Mar 16, 2017·Clinical Cardiology·Deepak L BhattUNKNOWN REDUCE-IT Investigators
Feb 18, 2017·Journal of the American College of Cardiology·Daniel J RaderSumeet A Khetarpal
Nov 3, 2016·Journal of Lipid Research·Børge G Nordestgaard, Anne Langsted
May 27, 2017·Current Opinion in Lipidology·Anette Varbo, Børge G Nordestgaard
Apr 2, 2017·Canadian Journal of Diabetes·Louis-Jacques CartierPierre Douville
Jul 12, 2017·Expert Review of Proteomics·Laura Mourino-AlvarezMaria G Barderas
Feb 9, 2018·Nature Reviews. Cardiology·Børge G NordestgaardAnne Tybjærg-Hansen
Mar 21, 2018·Current Atherosclerosis Reports·Kevin C Maki, Mary R Dicklin
Sep 20, 2017·Journal of Clinical Medicine·Mohammed A I Al-ObaideTetyana L Vasylyeva
Nov 14, 2017·Journal of Internal Medicine·S B PedersenB G Nordestgaard
Dec 12, 2017·European Heart Journal·Christian M MadsenBørge G Nordestgaard
Dec 9, 2017·Medicine and Science in Sports and Exercise·Catherine M PhillipsIvan J Perry
Sep 26, 2017·DNA and Cell Biology·Anbo GaoYuncheng Lv
Aug 4, 2018·Nutrients·Nur Zuliani RamliFairus Ahmad
Aug 24, 2017·Praxis·Arnold von Eckardstein
Aug 24, 2018·Journal of Atherosclerosis and Thrombosis·Makoto KinoshitaUNKNOWN Committee for Epidemiology and Clinical Management of Atherosclerosis
Oct 28, 2016·Arteriosclerosis, Thrombosis, and Vascular Biology·Anette Varbo, Børge G Nordestgaard
Jan 6, 2018·Circulation Research·Lisa Honold, Matthias Nahrendorf
Dec 11, 2017·Journal of the American Heart Association·Patrick R LawlerSamia Mora
Nov 4, 2017·Arteriosclerosis, Thrombosis, and Vascular Biology·Anette Varbo, Børge G Nordestgaard
Jul 1, 2017·Arteriosclerosis, Thrombosis, and Vascular Biology·Mikael Rydén, Peter Arner
Nov 15, 2018·European Journal of Preventive Cardiology·Barak ZafrirErez Sharoni
Jan 25, 2019·Arteriosclerosis, Thrombosis, and Vascular Biology·Lars E LarsenAdriaan G Holleboom
Jan 18, 2019·Circulation Research·Dennis Wolf, Klaus Ley
Feb 1, 2019·Arteriosclerosis, Thrombosis, and Vascular Biology·Mikio TakanashiHiroaki Okazaki

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Inflammation

Inflammation plays a significant role in the development of cardiovascular diseases, an understanding of these endogenous processes is critical for evaluating the risks and potential treatment strategies. Discover the latest research on cardiovascular inflammation here.

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Brain Ischemia

Brain ischemia is a condition in which there is insufficient blood flow to the brain to meet metabolic demand. Discover the latest research on brain ischemia here.

Atherosclerosis Disease Progression

Atherosclerosis is the buildup of plaque on artery walls, causing stenosis which can eventually lead to clinically apparent cardiovascular disease. Find the latest research on atherosclerosis disease progression here.